An "AI pharmaceutical company" has emerged, with 37,000 AI (artificial intelligence) researchers who neither eat nor sleep, ...

Why a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody ...

KRTL outlines how expanded regulatory leadership expects to support its developing South American API, botanical, controlled substance, and pharmaceutical strategyLakewood, CO, Sept. 16, 2026 (GLOBE ...

With oral cyclic peptides offering small molecule convenience and antibody‑like selectivity, the modality is gaining momentum ...

Researchers developed a ‘virtual biotech’ made up of as many as 37,000 agents reporting to an 'chief scientist'.

The initiative combines coursework, networking, and a task force to provide scientists with real-world knowledge on drug ...

An FDA pilot program to speed up drug development, Democrats plan health care probes after midterms, and more biotech news ...

New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and ...

The biotech company is downsizing to fund another trial after a drug showed no meaningful benefit. The move comes just a year ...

Americans will soon be able to travel to Big Sky Country to take experimental drugs in defiance of federal regulators.